TetraQ operates within a quality framework in compliance with the following international standards:
• OECD Principles of Good Laboratory Practice (GLP)
• ISO 17025 (R&D) accreditation
• FDA Good Laboratory Practice for Nonclinical Laboratory Studies (21CFR58)
• FDA Electronic Records; Electronic Signatures (21CFR11)
TetraQ's accreditation includes accredited ELISA testing in its services to Australian and international biopharmaceutical organisations.
GLP compliance ensures that data from relevant preclinical studies will be accepted for international regulatory review e.g. FDA. This is a consequence of the Australian GLP monitoring body, NATA (National Association of Testing Authorities), being a signatory to an international agreement for the mutual acceptance of data. ISO 17025 (R&D) accreditation recognises the technical competency of TetraQ's facility. TetraQ has been audited by clients and authorities.
The Australian National Association of Testing Authorities (NATA) is the oldest laboratory accreditation body in the world.